These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 15190197)
1. Treatment of lysosomal storage disorders: cell therapy and gene therapy. Eto Y; Shen JS; Meng XL; Ohashi T J Inherit Metab Dis; 2004; 27(3):411-5. PubMed ID: 15190197 [TBL] [Abstract][Full Text] [Related]
2. Brain transplantation of genetically engineered human neural stem cells globally corrects brain lesions in the mucopolysaccharidosis type VII mouse. Meng XL; Shen JS; Ohashi T; Maeda H; Kim SU; Eto Y J Neurosci Res; 2003 Oct; 74(2):266-77. PubMed ID: 14515356 [TBL] [Abstract][Full Text] [Related]
3. In utero fetal liver cell transplantation without toxic irradiation alleviates lysosomal storage in mice with mucopolysaccharidosis type VII. Barker JE; Deveau S; Lessard M; Hamblen N; Vogler C; Levy B Blood Cells Mol Dis; 2001; 27(5):861-73. PubMed ID: 11783949 [TBL] [Abstract][Full Text] [Related]
4. Functional correction of CNS phenotypes in a lysosomal storage disease model using adeno-associated virus type 4 vectors. Liu G; Martins I; Wemmie JA; Chiorini JA; Davidson BL J Neurosci; 2005 Oct; 25(41):9321-7. PubMed ID: 16221840 [TBL] [Abstract][Full Text] [Related]
5. Widespread gene transduction to the central nervous system by adenovirus in utero: implication for prenatal gene therapy to brain involvement of lysosomal storage disease. Shen JS; Meng XL; Maeda H; Ohashi T; Eto Y J Gene Med; 2004 Nov; 6(11):1206-15. PubMed ID: 15459963 [TBL] [Abstract][Full Text] [Related]
6. Gene therapy/cell therapy for lysosomal storage disease. Eto Y; Ohashi T J Inherit Metab Dis; 2000 May; 23(3):293-8. PubMed ID: 10863945 [TBL] [Abstract][Full Text] [Related]
7. Extensive beta-glucuronidase activity in murine central nervous system after adenovirus-mediated gene transfer to brain. Ghodsi A; Stein C; Derksen T; Yang G; Anderson RD; Davidson BL Hum Gene Ther; 1998 Nov; 9(16):2331-40. PubMed ID: 9829532 [TBL] [Abstract][Full Text] [Related]
8. Neural progenitor cell engraftment corrects lysosomal storage throughout the MPS VII mouse brain. Snyder EY; Taylor RM; Wolfe JH Nature; 1995 Mar; 374(6520):367-70. PubMed ID: 7885477 [TBL] [Abstract][Full Text] [Related]
9. Widespread correction of lysosomal storage following intrahepatic injection of a recombinant adeno-associated virus in the adult MPS VII mouse. Sferra TJ; Backstrom K; Wang C; Rennard R; Miller M; Hu Y Mol Ther; 2004 Sep; 10(3):478-91. PubMed ID: 15336648 [TBL] [Abstract][Full Text] [Related]
10. Intraventricular administration of recombinant adenovirus to neonatal twitcher mouse leads to clinicopathological improvements. Shen JS; Watabe K; Ohashi T; Eto Y Gene Ther; 2001 Jul; 8(14):1081-7. PubMed ID: 11526455 [TBL] [Abstract][Full Text] [Related]
11. Recombinant adeno-associated virus-mediated correction of lysosomal storage within the central nervous system of the adult mucopolysaccharidosis type VII mouse. Sferra TJ; Qu G; McNeely D; Rennard R; Clark KR; Lo WD; Johnson PR Hum Gene Ther; 2000 Mar; 11(4):507-19. PubMed ID: 10724030 [TBL] [Abstract][Full Text] [Related]
12. Comparison of ventricular and intravenous lentiviral-mediated gene therapy for murine MPS VII. Bielicki J; McIntyre C; Anson DS Mol Genet Metab; 2010 Dec; 101(4):370-82. PubMed ID: 20864369 [TBL] [Abstract][Full Text] [Related]
13. Functional correction of established central nervous system deficits in an animal model of lysosomal storage disease with feline immunodeficiency virus-based vectors. Brooks AI; Stein CS; Hughes SM; Heth J; McCray PM; Sauter SL; Johnston JC; Cory-Slechta DA; Federoff HJ; Davidson BL Proc Natl Acad Sci U S A; 2002 Apr; 99(9):6216-21. PubMed ID: 11959904 [TBL] [Abstract][Full Text] [Related]
14. Histopathological and behavioral improvement of murine mucopolysaccharidosis type VII by intracerebral transplantation of neural stem cells. Fukuhara Y; Li XK; Kitazawa Y; Inagaki M; Matsuoka K; Kosuga M; Kosaki R; Shimazaki T; Endo H; Umezawa A; Okano H; Takahashi T; Okuyama T Mol Ther; 2006 Mar; 13(3):548-55. PubMed ID: 16316785 [TBL] [Abstract][Full Text] [Related]
15. Engraftment of genetically engineered amniotic epithelial cells corrects lysosomal storage in multiple areas of the brain in mucopolysaccharidosis type VII mice. Kosuga M; Sasaki K; Tanabe A; Li XK; Okawa H; Ogino I; Okuda O; Arai H; Sakuragawa N; Kamata Y; Azuma N; Suzuki S; Yamada M; Okuyama T Mol Ther; 2001 Feb; 3(2):139-48. PubMed ID: 11237670 [TBL] [Abstract][Full Text] [Related]
16. Enzyme replacement in murine mucopolysaccharidosis type VII: neuronal and glial response to beta-glucuronidase requires early initiation of enzyme replacement therapy. Vogler C; Levy B; Galvin NJ; Thorpe C; Sands MS; Barker JE; Baty J; Birkenmeier EH; Sly WS Pediatr Res; 1999 Jun; 45(6):838-44. PubMed ID: 10367775 [TBL] [Abstract][Full Text] [Related]
18. CNS-targeted AAV5 gene transfer results in global dispersal of vector and prevention of morphological and function deterioration in CNS of globoid cell leukodystrophy mouse model. Lin DS; Hsiao CD; Liau I; Lin SP; Chiang MF; Chuang CK; Wang TJ; Wu TY; Jian YR; Huang SF; Liu HL Mol Genet Metab; 2011 Aug; 103(4):367-77. PubMed ID: 21620749 [TBL] [Abstract][Full Text] [Related]
20. Enzyme replacement with recombinant beta-glucuronidase in murine mucopolysaccharidosis type VII: impact of therapy during the first six weeks of life on subsequent lysosomal storage, growth, and survival. Vogler C; Sands MS; Levy B; Galvin N; Birkenmeier EH; Sly WS Pediatr Res; 1996 Jun; 39(6):1050-4. PubMed ID: 8725268 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]